Edition:
United States

Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

21.40USD
9 Dec 2016
Change (% chg)

$0.20 (+0.94%)
Prev Close
$21.20
Open
$21.25
Day's High
$22.15
Day's Low
$20.98
Volume
368,712
Avg. Vol
601,629
52-wk High
$43.63
52-wk Low
$16.40

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.10 December 10 Dec 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 3
(3) HOLD 3 3 3 4
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.56

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 9 137.95 141.32 136.20 135.76
Quarter Ending Mar-17 2 128.02 129.65 126.40 --
Year Ending Dec-16 9 516.05 520.00 505.96 514.48
Year Ending Dec-17 8 542.33 567.20 461.86 547.85
Earnings (per share)
Quarter Ending Dec-16 6 0.10 0.25 -0.05 0.20
Quarter Ending Mar-17 2 -0.08 0.02 -0.18 --
Year Ending Dec-16 6 0.19 0.35 0.05 1.05
Year Ending Dec-17 5 0.75 1.50 0.07 1.12

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 134.01 135.61 1.61 1.20
Quarter Ending Jun-16 128.66 127.46 1.20 0.93
Quarter Ending Mar-16 115.36 115.90 0.54 0.47
Quarter Ending Sep-15 115.52 148.20 32.68 28.29
Quarter Ending Mar-15 100.22 99.85 0.37 0.37
Earnings (per share)
Quarter Ending Sep-16 0.11 -0.04 0.15 136.36
Quarter Ending Jun-16 0.20 0.07 0.13 64.70
Quarter Ending Mar-16 0.08 0.07 0.01 10.26
Quarter Ending Dec-15 0.22 0.28 0.06 24.83
Quarter Ending Sep-15 0.15 0.31 0.16 110.74

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 137.95 137.95 137.82 138.71 135.76
Quarter Ending Mar-17 128.02 128.02 128.02 130.95 --
Year Ending Dec-16 516.05 516.05 511.83 511.49 514.48
Year Ending Dec-17 542.33 542.33 542.81 550.61 547.85
Earnings (per share)
Quarter Ending Dec-16 0.10 0.10 0.10 0.14 0.20
Quarter Ending Mar-17 -0.08 -0.08 -0.08 -- --
Year Ending Dec-16 0.19 0.19 0.28 0.47 1.05
Year Ending Dec-17 0.75 0.75 0.24 0.51 1.12

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-16 0 0 0 0
Quarter Ending Mar-17 0 0 0 0
Year Ending Dec-16 0 0 1 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Dec-16 0 0 0 0
Quarter Ending Mar-17 0 0 0 0
Year Ending Dec-16 0 0 0 1
Year Ending Dec-17 0 0 2 0